CASI Pharmaceuticals Inc

NASDAQ:CASI  
1.40
-0.02 (-1.41%)
Earnings Announcements

Casi Pharmaceuticals Announces Second Quarter 2021 Financial Results

Published: 08/12/2021 11:13 GMT
CASI Pharmaceuticals Inc (CASI) - Casi Pharmaceuticals Announces Second Quarter 2021 Financial Results.
Q2 Revenue $7.1 Million Versus Refinitiv Ibes Estimate of $6 Million.
Quarterly Loss per Share $0.05.
Revenue is expected to be $7.53 Million
Adjusted EPS is expected to be -$0.06

Next Quarter Revenue Guidance is expected to be $8.07 Million
Next Quarter EPS Guidance is expected to be -$0.06

More details on our Analysts Page.